Merck To Pay $100M To End NuvaRing Blood Clot Suits
Merck & Co. has finalized an agreement to pay $100 million to settle all state and federal suits in the U.S. alleging its NuvaRing birth control causes fatal blood clots, the...To view the full article, register now.
Already a subscriber? Click here to view full article